Pharmaceutical Raw Materials and Excipients No Further a Mystery
“The current condition has uncovered some structural weaknesses in the EU’s medicines source chain and also a high dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides mentioned. She suggested that provide chain challenges be addressed within an EU pharmaceutical system expected to generally be launched by the top